Laurion Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Laurion Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,300	Closed	-$342K	–	2056
2017 Q2	$342K	Buy	+3,300	New	+$269K	﹤0.01%	1382
2016 Q4	–	Sell	-33,300	Closed	-$1.86M	–	1395
2016 Q3	$1.86M	Buy	+33,300	New	+$1.86M	0.02%	490
2015 Q3	–	Sell	-6,167	Closed	-$376K	–	1011
2015 Q2	$376K	Sell	6,167 -1,500	-20%	-$85.6K	﹤0.01%	507
2015 Q1	$442K	Buy	+7,667	New	+$514K	0.01%	256

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Laurion Capital Management's KITE Position: Q3 2017 in Review

Laurion Capital Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 3,300 shares — an estimated $342K sold.

Laurion Capital Management first reported a position in KITE in Q1 2015 and held it in 4 quarters. The position peaked at $1.86M in Q3 2016. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Laurion Capital Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Laurion Capital Management sold 3,300 Kite Pharma, Inc. shares in Q3 2017, an estimated $342K.
Laurion Capital Management first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 4 quarters.
Laurion Capital Management's Kite Pharma, Inc. position peaked at $1.86M in Q3 2016.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Laurion Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.